Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-052101
Filing Date
2024-12-26
Accepted
2024-12-26 16:15:08
Documents
1
Period of Report
2024-12-23

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 6734
  Complete submission text file 0001493152-24-052101.txt   8766
Mailing Address 1455 NW LEARY WAY SUITE 400 SEATTLE WA 98107
Business Address 1455 NW LEARY WAY SUITE 400 SEATTLE WA 98107 206-227-3078
22NW Fund, LP (Reporting) CIK: 0001640809 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40388 | Film No.: 241581253

Mailing Address 1455 NW LEARY WAY, SUITE 400 SEATTLE WA 98107
Business Address
English Aron R. (Reporting) CIK: 0001770436 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40388 | Film No.: 241581254

Mailing Address JFL CAPITAL MANAGEMENT 1017 RR 620 S, SUITE 107 LAKEWAY TX 78734
Business Address JFL CAPITAL MANAGEMENT 1017 RR 620 S, SUITE 107 LAKEWAY TX 78734 737 203 5270
Anebulo Pharmaceuticals, Inc. (Issuer) CIK: 0001815974 (see all company filings)

EIN.: 851170950 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)